SG11201808528VA - Modified wound dressings - Google Patents

Modified wound dressings

Info

Publication number
SG11201808528VA
SG11201808528VA SG11201808528VA SG11201808528VA SG11201808528VA SG 11201808528V A SG11201808528V A SG 11201808528VA SG 11201808528V A SG11201808528V A SG 11201808528VA SG 11201808528V A SG11201808528V A SG 11201808528VA SG 11201808528V A SG11201808528V A SG 11201808528VA
Authority
SG
Singapore
Prior art keywords
international
wounds
rule
applicant
chronic
Prior art date
Application number
SG11201808528VA
Inventor
Lucy Ballamy
Original Assignee
Convatec Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Convatec Technologies Inc filed Critical Convatec Technologies Inc
Publication of SG11201808528VA publication Critical patent/SG11201808528VA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
    • A61K49/0043—Fluorescein, used in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/00051—Accessories for dressings
    • A61F13/00063—Accessories for dressings comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0054—Macromolecular compounds, i.e. oligomers, polymers, dendrimers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0056—Peptides, proteins, polyamino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
    • A61K49/0073—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form semi-solid, gel, hydrogel, ointment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/38—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/56—Wetness-indicators or colourants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/60—Liquid-swellable gel-forming materials, e.g. super-absorbents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A61L2300/254—Enzymes, proenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/442—Colorants, dyes

Abstract

INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property -, Organization 111111110111101110101011111010111110111010111111110101111101111101111011111 International Bureau ... .... ..Yjd (10) International Publication Number (43) International Publication Date ..... ...r .....1 WO 2017/173026 Al 5 October 2017 (05.10.2017) IN I PO I P CT (51) International Patent Classification: BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, A61K 31/455 (2006.01) A61K 9/06 (2006.01) DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, A61K 31/726 (2006.01) HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, (21) International Application Number: MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, PCT/US2017/024915 NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, (22) International Filing Date: RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, 30 March 2017 (30.03.2017) TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (25) Filing Language: English (84) Designated States (unless otherwise indicated, for every (26) Publication Language: English kind of regional protection available): ARIPO (BW, GH, (30) Priority Data: GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, 62/315,567 30 March 2016 (30.03.2016) US TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, (71) Applicant: CONVATEC TECHNOLOGIES INC. DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, [US/US]; 3993 Howard Hughes Parkway, Suite 250, Las LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, Vegas, Nevada 89169 (US). SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, (72) Inventor: BALLAMY, Lucy; 4 Fron Castell, Fron Bache, GW, KM, ML, MR, NE, SN, TD, TG). Llangollen Denbighshire LL207BX (GB). Declarations under Rule 4.17: (74) Agent: WESTIN, Lorelei P.; WILSON SONSINI — as to applicant's entitlement to apply for and be granted a GOODRICH & ROSATI, 650 Page Mill Road, Palo Alto, patent (Rule 4.17(ii)) California 94304 (US). — as to the applicant's entitlement to claim the priority of the (81) Designated States (unless otherwise indicated, for every earlier application (Rule 4.17(iii)) kind of national protection available): AE, AG, AL, AM, = AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, [Continued on next page] = = (54) Title: MODIFIED WOUND DRESSINGS (57) : Embodiments described herein relate to compounds for the detection of wounds, e.g., chronic wounds or infected wounds, including — FIG. 14 compositions, substrates, kits, dressing materials, and articles, and systems = = _ M erited Llattt w containing such compounds. Further embodiments relate to methods of us- ing these compositions, kits and systems in diagnostic assays, and in the dia- gnosis and/or detection of chronic or infected wounds based on enzymatic conversion of specific substrates which are contained in the compositions. = - — = C Additional embodiments relate to methods of characterizing wounds based on expression of a plurality of markers and using such information to treat, manage, and follow-up patients suffering from chronic or infected wounds. = PEA Spacer I = I = _ Protease 1-1 EC 11- 1 - N © OTS t_,. -An'le IN en ,-1 (a) (b) (c) IN ,-1 © N O WO 2017/173026 Al MIDEDIMOMONIIMMEOMME11100 1101 HIMOVOIMIE Published: — before the expiration of the time limit for amending the — with international search report (Art. 21(3)) claims and to be republished in amendments (Rule 48.2(h)) the event of receipt of
SG11201808528VA 2016-03-30 2017-03-30 Modified wound dressings SG11201808528VA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662315567P 2016-03-30 2016-03-30
PCT/US2017/024915 WO2017173026A1 (en) 2016-03-30 2017-03-30 Modified wound dressings

Publications (1)

Publication Number Publication Date
SG11201808528VA true SG11201808528VA (en) 2018-10-30

Family

ID=59965163

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201808528VA SG11201808528VA (en) 2016-03-30 2017-03-30 Modified wound dressings

Country Status (19)

Country Link
US (3) US20190307904A1 (en)
EP (1) EP3436012B1 (en)
JP (2) JP7394526B2 (en)
KR (1) KR20180132093A (en)
CN (1) CN109219436A (en)
AR (1) AR108054A1 (en)
AU (1) AU2017244116C1 (en)
BR (1) BR112018070191A2 (en)
CA (1) CA3019548A1 (en)
CL (1) CL2018002782A1 (en)
CO (1) CO2018011720A2 (en)
EC (1) ECSP18081922A (en)
IL (1) IL262011A (en)
MX (1) MX2018011811A (en)
PL (1) PL3436012T3 (en)
SG (1) SG11201808528VA (en)
TW (1) TW201806625A (en)
UY (1) UY37176A (en)
WO (1) WO2017173026A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0808376D0 (en) 2008-05-08 2008-06-18 Bristol Myers Squibb Co Wound dressing
AU2017243601A1 (en) 2016-03-30 2018-11-22 Acib Gmbh Detecting microbial infection in wounds
MX2018011811A (en) 2016-03-30 2019-08-21 Convatec Technologies Inc Modified wound dressings.
HRP20221427T1 (en) 2017-10-06 2023-01-06 Eluciderm Inc. Compositions and methods for wound treatment
US11491042B2 (en) 2017-11-09 2022-11-08 11 Health And Technologies Limited Ostomy monitoring system and method
JP2022506749A (en) * 2018-11-02 2022-01-17 ファウント バイオ， インコーポレイテッド Material to be crosslinked
USD893514S1 (en) 2018-11-08 2020-08-18 11 Health And Technologies Limited Display screen or portion thereof with graphical user interface
EP4031112A4 (en) * 2019-09-19 2023-10-11 Ohio State Innovation Foundation Nanofiber- and nanowhisker-based transfection platforms
WO2021087008A1 (en) * 2019-10-28 2021-05-06 Brown University Bacterial beta-lactamase responsive hydrogels
EP4057908A4 (en) * 2019-11-14 2023-11-22 Bruin Biometrics, LLC Ultrasound imaging
CN111012944A (en) * 2019-12-30 2020-04-17 山东星之诚生物科技有限公司 Liquid dressing based on alginate and hyaluronic acid and preparation method thereof
CN111330069A (en) * 2020-03-09 2020-06-26 蔡钧 External dressing and preparation method and application thereof
CN112358646B (en) * 2020-10-20 2023-03-31 湖北大学 Preparation method and application of fluorescent hydrogel dressing
CN112341638B (en) * 2020-11-05 2022-07-15 云南师范大学 Hydrogel material with porous structure and preparation and application thereof
CN112370567B (en) * 2020-11-19 2023-05-16 南方医科大学南方医院 Hydrogel active dressing with antibacterial and anti-inflammatory functions
CN112980003B (en) * 2021-04-16 2022-06-28 中国药科大学 Natural polysaccharide based antibacterial hydrogel, preparation method and application
CN114470297B (en) * 2021-12-20 2022-09-13 山西医科大学 Sugar-triggered response type wound quick-healing dressing and preparation method thereof
CN114835722B (en) * 2022-05-12 2023-03-21 大连理工大学 Synthesis and application of alanine aminopeptidase fluorescent probe for determining pesticide residues
CN115920119A (en) * 2022-11-18 2023-04-07 常州大学 Gelatinase responsive photothermal oxygen-carrying hydrogel wound dressing and preparation method thereof

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4737456A (en) 1985-05-09 1988-04-12 Syntex (U.S.A.) Inc. Reducing interference in ligand-receptor binding assays
DE3783073T2 (en) * 1986-04-22 1993-04-29 Ajinomoto Kk MODIFIED CELLULOSE GEL MADE BY MICROORGANISMS AND ITS COMPLEX WITH ANIMAL CELLS.
WO1993004192A1 (en) * 1991-08-23 1993-03-04 Molecular Probes, Inc. Use of haloalkyl derivatives of reporter molecules to analyze metabolic activity in cells
US6207392B1 (en) 1997-11-25 2001-03-27 The Regents Of The University Of California Semiconductor nanocrystal probes for biological applications and process for making and using such probes
GB2381452B (en) 2001-11-05 2005-08-10 Johnson & Johnson Medical Ltd Wound monitoring
US20040101547A1 (en) * 2002-11-26 2004-05-27 Pendharkar Sanyog Manohar Wound dressing containing aldehyde-modified regenerated polysaccharide
GB0224986D0 (en) 2002-10-28 2002-12-04 Smith & Nephew Apparatus
US7544640B2 (en) 2002-12-10 2009-06-09 Halliburton Energy Services, Inc. Zeolite-containing treating fluid
CA2511205C (en) * 2002-12-26 2009-07-14 Otsuka Chemical Co., Ltd. Sugar-chain asparagine derivatives and processes for the preparation thereof
US7148194B2 (en) 2002-12-30 2006-12-12 Kimberly-Clark Worldwide, Inc. Method to increase fibronectin
JP4490290B2 (en) 2002-12-31 2010-06-23 ネクター セラピューティクス アラバマ，コーポレイション Hydrolytically stable maleimide terminated polymer
WO2006080951A2 (en) * 2004-07-01 2006-08-03 Yale University Targeted and high density drug loaded polymeric materials
EP2007360B1 (en) 2006-04-03 2014-11-26 Isa Odidi Controlled release delivery device comprising an organosol coat
PT2433138T (en) 2009-05-18 2016-12-19 Technische Universität Graz Method for detecting a wound infection
CA2793354C (en) 2010-04-07 2016-06-21 Comvita New Zealand Limited Gel composition
GB201012333D0 (en) 2010-07-22 2010-09-08 Convatec Technologies Inc Fibres, a process for producing such fibres and a wound dressing incorporating them
GB201020193D0 (en) * 2010-11-29 2011-01-12 Biotec Pharmacon Asa Glucan compositions
WO2012074509A1 (en) 2010-11-30 2012-06-07 Avery Dennison Corporation Sensing patch applications
US9932622B2 (en) * 2011-01-31 2018-04-03 Woundchek Laboratories B.V. Wound prognosis
FR2977491B1 (en) 2011-07-05 2013-07-26 Melvita Production COSMETIC COMPOSITION COMPRISING A MIXTURE OF HONEY
US20120183585A1 (en) * 2012-02-25 2012-07-19 Rassoul Dinarvand Gel based wound dressing and a method of synthesizing the same
US9139718B2 (en) * 2012-12-20 2015-09-22 E I Du Pont De Nemours And Company Preparation of poly alpha-1,3-glucan ethers
KR20150119848A (en) 2012-12-21 2015-10-26 바이오얼라이언스 씨.브이. Hydrophilic self-immolative linkers and conjugates thereof
US11433092B2 (en) * 2013-03-15 2022-09-06 Synedgen, Inc. Compositions and methods of use for wound healing
AU2014247614B2 (en) 2013-03-30 2017-09-21 Glytech, Inc. (sugar chain)-polypeptide complex
US20150143467A1 (en) 2013-11-19 2015-05-21 Intel-Ge Care Innovations Llc System and method for facilitating communication between a web application and a local peripheral device through a native service
EP3662876B1 (en) 2016-03-01 2023-03-01 3M Innovative Properties Company Drape for use with medical therapy systems
MX2018011811A (en) 2016-03-30 2019-08-21 Convatec Technologies Inc Modified wound dressings.
TW201800069A (en) 2016-03-30 2018-01-01 康華特科技有限公司 Detecting microbial infection in wounds

Also Published As

Publication number Publication date
US20240123091A1 (en) 2024-04-18
WO2017173026A1 (en) 2017-10-05
BR112018070191A2 (en) 2019-01-29
JP7395630B2 (en) 2023-12-11
CA3019548A1 (en) 2017-10-05
AR108054A1 (en) 2018-07-11
IL262011A (en) 2018-10-31
US20190307904A1 (en) 2019-10-10
JP2022065128A (en) 2022-04-26
PL3436012T3 (en) 2024-04-08
EP3436012A1 (en) 2019-02-06
AU2017244116A1 (en) 2018-11-15
KR20180132093A (en) 2018-12-11
EP3436012A4 (en) 2019-10-23
JP2019509853A (en) 2019-04-11
EP3436012B1 (en) 2023-09-20
EP3436012C0 (en) 2023-09-20
UY37176A (en) 2017-10-31
ECSP18081922A (en) 2019-02-28
MX2018011811A (en) 2019-08-21
CN109219436A (en) 2019-01-15
JP7394526B2 (en) 2023-12-08
AU2017244116B2 (en) 2023-03-02
TW201806625A (en) 2018-03-01
CL2018002782A1 (en) 2019-03-15
AU2017244116C1 (en) 2023-06-01
US20210275693A1 (en) 2021-09-09
JP7395630B6 (en) 2024-01-23
US11865192B2 (en) 2024-01-09
CO2018011720A2 (en) 2018-11-13

Similar Documents

Publication Publication Date Title
SG11201808528VA (en) Modified wound dressings
SG11201808990QA (en) Compositions for topical application of compounds
SG11201901841TA (en) Targeting ligands
SG11201909955XA (en) Formulations of anti-lag3 antibodies and co-formulations of anti-lag3 antibodies and anti-pd-1 antibodies
SG11201908478SA (en) Sterilisation method
SG11201909011PA (en) Niraparib compositions
SG11201803983UA (en) Transformable tagging compositions, methods, and processes incorporating same
SG11201909432SA (en) Compounds for increasing genome editing efficiency
SG11201908719QA (en) Biomarkers and car t cell therapies with enhanced efficacy
SG11201901531TA (en) Regulation of gene expression using engineered nucleases
SG11201906386XA (en) Combination therapy involving diaryl macrocyclic compounds
SG11201805300QA (en) Heterocyclic compounds as immunomodulators
SG11201900163PA (en) Macrocycle kinase inhibitors
SG11201900349VA (en) Somatostatin modulators and uses thereof
SG11201908512YA (en) Somatostatin modulators and uses thereof
SG11201909155VA (en) Ask1 inhibitor compounds and uses thereof
SG11201900464TA (en) HUMANIZED MONOCLONAL ANTIBODIES THAT TARGET VE-PTP (HPTP-ß)
SG11201808306PA (en) Treatment of cancer with tg02
SG11201406903SA (en) Cell culture compositions and methods for polypeptide production
SG11201406973PA (en) Complement pathway modulators and uses thereof
SG11201809908TA (en) Stabilized glycopeptide antibiotic formulations
SG11201907764PA (en) Methods for screening infections
SG11201408808WA (en) Method and system for treatment of biological tissue
SG11201901228QA (en) Chromatography method for quantifying a non-ionic surfactant in a composition comprising the non-ionic surfactant and a polypeptide
SG11201809875VA (en) Compositions and methods for treating spinal muscular atrophy